ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #204Top JournalHybrid

Lancet Rheumatology

Identifier (ISSN):2665-9913(Print)
•
Publisher:ELSEVIER
Clarivate IF (2026)
29.5↑ +13.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2022–2026)

Clarivate IF trend for Lancet Rheumatology

WoS Q1
1022344635.5202225.4202315.0202416.4202529.52026
Annual Impact Factor Metric
Current (2026):29.5
Scopus SJR & RankScopus Q1
6.167
#204

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
66

66 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate2.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
67articles/year
24.34% Gold OA•89.47% Original Research

Aims & Scope

Lancet Rheumatology (ISSN: 2665-9913) is a peer-reviewed international scholarly journal in the field of RHEUMATOLOGY, published by ELSEVIER in England. The periodical holds a Journal Impact Factor (JIF) of 29.5, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 6.167 (Q1), an H-index of 66.

Topics Covered (Recognized by AI)
Medicine81.5%Internal medicine73.9%Biology69.6%Pathology67.3%Immunology51%Disease48.2%Genetics36.4%Psychology33.4%Surgery28.4%Infectious disease (medical specialty)25.7%Coronavirus disease 2019 (COVID-19)25.6%Psychiatry25.1%Rheumatoid arthritis21.5%Virology21.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

RHEUMATOLOGY

Q1
Rank2/58
IndexSCIE
JCISCIE2026

RHEUMATOLOGY

Q1
Rank3/58
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

8 year
2026Latest
IF29.5
Articles / Year140
Total Citations107
2025
IF16.4
Articles / Year187
Total Citations916
2024
IF15
Articles / Year210
Total Citations2,799
2023
IF25.4
Articles / Year163
Total Citations7,268
2022
IF35.482
Articles / Year198
Total Citations2,574

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #204Scopus Q1SCImago Profile
Scopus Coverage:2019-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q1
6.167

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
11.45

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,478 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations4,032
3-Year Documents496
Citable Documents191

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ1
Immunology and AllergyQ1
RheumatologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区RHEUMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Lancet Rheumatology (ISSN: 2665-9913) is a peer-reviewed international scholarly journal in the field of RHEUMATOLOGY, published by ELSEVIER in England. The periodical holds a Journal Impact Factor (JIF) of 29.5, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 6.167 (Q1), an H-index of 66.

The journal enforces rigorous peer evaluation with an annual output of approximately 67 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,478 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
ELSEVIER
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusPubMed
Editorial Address
RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 278c77c4-4fd4-45e5-9f1c-716e9e2f35f2
Database Updated: 2026-10-16